GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pharmarise Holdings Corp (TSE:2796) » Definitions » Cost of Goods Sold

Pharmarise Holdings (TSE:2796) Cost of Goods Sold : 円46,017 Mil (TTM As of May. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Pharmarise Holdings Cost of Goods Sold?

Pharmarise Holdings's cost of goods sold for the three months ended in May. 2024 was 円11,798 Mil. Its cost of goods sold for the trailing twelve months (TTM) ended in May. 2024 was 円46,017 Mil.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Pharmarise Holdings's Gross Margin % for the three months ended in May. 2024 was 14.46%.

Cost of Goods Sold is also directly linked to Inventory Turnover. Pharmarise Holdings's Inventory Turnover for the three months ended in May. 2024 was 3.95.


Pharmarise Holdings Cost of Goods Sold Historical Data

The historical data trend for Pharmarise Holdings's Cost of Goods Sold can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmarise Holdings Cost of Goods Sold Chart

Pharmarise Holdings Annual Data
Trend May15 May16 May17 May18 May19 May20 May21 May22 May23 May24
Cost of Goods Sold
Get a 7-Day Free Trial Premium Member Only Premium Member Only 43,593.00 44,257.00 43,491.00 43,896.00 46,017.00

Pharmarise Holdings Quarterly Data
Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24
Cost of Goods Sold Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11,179.00 11,341.00 11,337.00 11,541.00 11,798.00

Pharmarise Holdings Cost of Goods Sold Calculation

Cost of Goods Sold is the aggregate cost of goods produced and sold, and services rendered during the reporting period. It excludes Total Operating Expense, such as Depreciation, Depletion and Amortization and Selling, General, & Admin. Expense.

Cost of Goods Sold for the trailing twelve months (TTM) ended in May. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円46,017 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharmarise Holdings  (TSE:2796) Cost of Goods Sold Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Pharmarise Holdings's Gross Margin % for the three months ended in May. 2024 is calculated as:

Gross Margin %=(Revenue - Cost of Goods Sold) / Revenue
=(13792 - 11798) / 13792
=14.46 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Cost of Goods Sold is also directly linked to another concept called Inventory Turnover:

Pharmarise Holdings's Inventory Turnover for the three months ended in May. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher inventory turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate inventory turnover. An average inventory is a better indication.


Pharmarise Holdings Cost of Goods Sold Related Terms

Thank you for viewing the detailed overview of Pharmarise Holdings's Cost of Goods Sold provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmarise Holdings Business Description

Traded in Other Exchanges
N/A
Address
8 Floor, Sumitomo Nakano Sakue Building, 1-38-1 Chuo, Nakano-ku, Tokyo, JPN, 164-0011
Pharmarise Holdings Corp is engaged in the operation of dispensing pharmacies, which prescribe medicines to general patients based on prescriptions issued by medical institutions. It is also engaged in the storage and management of medical examination records of patients on behalf of the medical institution.

Pharmarise Holdings Headlines

No Headlines